Clene Nanomedicine Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Clene Nanomedicine's estimated annual revenue is currently $16.1M per year.(i)
  • Clene Nanomedicine's estimated revenue per employee is $201,000

Employee Data

  • Clene Nanomedicine has 80 Employees.(i)
  • Clene Nanomedicine grew their employee count by 31% last year.

Clene Nanomedicine's People

NameTitleEmail/Phone
1
V.P. ManufacturingReveal Email/Phone
2
VP, Quality & Technical OperationsReveal Email/Phone
3
Executive Director, Global Regulatory AffairsReveal Email/Phone
4
Director QC PChem and BioanalyticalReveal Email/Phone
5
Director, Quality EngineeringReveal Email/Phone
6
Executive Director Quality AssuranceReveal Email/Phone
7
CEO/PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.2M465%N/AN/A
#2
$17.3M864%N/AN/A
#3
$20.5M102-1%N/AN/A
#4
$7.6M38-3%N/AN/A
#5
$14.9M7437%N/AN/A
#6
$10.7M53-9%N/AN/A
#7
$6.2M317%N/AN/A
#8
$6.8M3413%N/AN/A
#9
$5.4M27-36%N/AN/A
#10
$305.9M15228%N/AN/A
Add Company

What Is Clene Nanomedicine?

Clene Nanomedicine, Inc. is a privately-held, clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland. This is an exciting time for us. We have been receiving many requests for more information. We hope you understand we cannot respond to individual requests. We instead invite you to visit our website, read our press releases, and check back for updates. For more information, please visit www.clene.com.

keywords:N/A

N/A

Total Funding

80

Number of Employees

$16.1M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Clene Nanomedicine News

2022-04-06 - VIDEO: Survival improved among ALS patients treated with ...

The nanotherapeutic CNM-Au8 (Clene Nanomedicine) is currently in development for treatment of patients with ALS, MS and Parkinson's disease.

2022-03-22 - Updated Interim Data from Clene Nanomedicine's RESCUE ...

Clene is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease by targeting energetic...

2022-03-22 - CNM-Au8 Data From the RESCUE-ALS Open-Label ...

Updated Interim Data from Clene Nanomedicine's RESCUE-ALS Open-Label Extension Study to be Presented in Emerging Science Program at 2022 AAN...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M804%N/A
#2
$8M8023%N/A
#3
$13.2M800%$26M
#4
$19.7M81-6%N/A
#5
$3.5M8125%N/A